v3.25.1
Accrued Liabilities (Tables)
3 Months Ended
Mar. 31, 2025
Accrued Liabilities, Current [Abstract]
Schedule of Accrued Liabilities
Accrued liabilities as of March 31, 2025 and December 31, 2024 consisted of the following (in thousands):
March 31,
2025
December 31,
2024
Contract research organization costs
$
24,375
$
30,250
Other clinical study related costs
2,026
2,161
Manufacturing and drug supply
5,278
9,941
Compensation and benefits
18,272
34,957
Professional fees
27,733
17,512
Gross to net accrued liabilities
33,369
21,703
Other
13,112
8,171
Total accrued liabilities
$
124,165
$
124,695
X
- References
No definition available.
+ Details
Name:
us-gaap_AccruedLiabilitiesCurrentAbstract
Namespace Prefix:
us-gaap_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Tabular disclosure of the components of accrued liabilities.
+ References
No definition available.
+ Details
Name:
us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix:
us-gaap_
Data Type:
dtr-types:textBlockItemType
Balance Type:
na
Period Type:
duration